Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol.
Vogelpoel, H;
Welink, J;
Amidon, GL;
Junginger, HE;
Midha, KK;
Möller, H;
Olling, M;
Shah, VP;
Barends, DM;
(2004)
Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol.
Journal of pharmaceutical sciences, 93 (8).
pp. 1945-1956.
ISSN 0022-3549
DOI: https://doi.org/10.1002/jps.20131
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Literature data related to the Biopharmaceutics Classification System (BCS) are presented on verapamil hydrochloride, propranolol hydrochloride, and atenolol in the form of BCS-monographs. Data on the qualitative composition of immediate release (IR) tablets containing these active substances with a Marketing Authorization (MA) in the Netherlands (NL) are also provided; in view of these MA's the assumption was made that these tablets were bioequivalent to the innovator product. The development of a database with BCS-related data is announced by the International Pharmaceutical Federation (FIP).